LOGIN  |  REGISTER
C4 Therapeutics

Etao (NASDAQ: ETAO) Stock Quote

Last Trade: US$3.00 0.05 1.52
Volume: 19,076
5-Day Change: -20.63%
YTD Change: 566.67%
Market Cap: US$15.360M

Latest News From Etao

This press release has been corrected to include further details regarding the reverse stock split of ETAO International Co., Ltd. We hereby issue a formal amendment to supersede our previously released press release dated March 19, 2024 . This amended communication is intended to replace the original statement in its entirety and provides updated, accurate information. We advise all stakeholders to refer to this latest... Read More
NEW YORK , Jan. 12, 2024 /PRNewswire/ -- ETAO International Co. Ltd. announced today that it received a staff determination – Delinquency letter (the "Letter"), on January 5, 2024 , from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company has not yet filed its interim financial statements for the period ended June 30, 2023 (the "Filing"), it no longer complies with our... Read More
NEW YORK , Dec. 21, 2023 /PRNewswire/ -- The board of directors (the "Board") of ETAO International Co. Ltd. (the "Company") approved the appointment of Ryoshin Nakade, as ETAO Japan president of the Company, effective on November 22, 2023 . Wensheng (Wilson) Liu , Chairman and CEO of ETAO stated, "We are thrilled about ETAO's new appointment of Ryoshin Nakade as ETAO Japan president. With the support of Mr. Ryoshin Nakade,... Read More
NEW YORK , Dec. 18, 2023 /PRNewswire/ -- ETAO International Co. Ltd. announced today that it received a staff determination letter (the "Letter"), on December 13, 2023 , from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company of the determination from the Nasdaq staff (the "Staff") to delist the Company's securities from The Nasdaq Stock Market, because, as of December 11,... Read More
NEW YORK , Oct. 12, 2023 /PRNewswire/ -- ETAO International Co. Ltd. announces its plan of reorganization to dispose seven of its twelve consolidated affiliates subsidiaries to trim its operations and improve profitability. On October 11, 2023 , pursuant to the terms of the Exclusive Business Cooperation Agreement, ETao Healthcare, the Company's indirectly subsidiary in China , notified Zhichao Medical Technology ( Hunan )... Read More
NEW YORK , June 22, 2023 /PRNewswire/ -- On June 14, 2023 , Etao International Co., Ltd. (the "Company") received a bid price deficiency letter from The Nasdaq Stock Market, LLC ("Nasdaq") notifying the Company that listed securities to maintain a minimum bid price of $1 per share. Based upon the closing bid price for the last 30 consecutive business days, the Company no longer meets this requirement. However, the Rules also... Read More
NEW YORK , May 26, 2023 /PRNewswire/ -- On May 18, 2023 , Etao International Co., Ltd. (the "Company") received a deficiency letter from The Nasdaq Stock Market, LLC ("Nasdaq") notifying the Company that it no longer complies with Nasdaq's Listing Rule 5250(c)(1) due to its failure to file Form 20-F for the period ended December 31, 2022 (the "Filing"). Nasdaq informed the Company that it has sixty (60) calendar days to... Read More
Surmodics

COPYRIGHT ©2023 HEALTH STOCKS HUB